Deuterated 1,4-benzodiazepine-2,5-dione compound and use thereof
Grant
US12577213B2
Kind: B2
Mar 17, 2026
Assignee
NINGBO COMBIREG PHARMACEUTICAL TECHNOLOGY CO., LTD.
Inventors
Gang Liu, Yao Ma, Wenjun Yu
Abstract
Disclosed are a deuterated 1,4-benzodiazepine-2,5-dione compound and the use thereof. Provided is a compound as represented by formula I or a pharmaceutically acceptable salt thereof. The disclosed 1,4-benzodiazepine-2,5-dione active compound maintains the activity of inhibiting tumor cells and tumor stem cells, and prolongs the degradation function of in-vitro human liver microsomes on the compound, such that the half-life period is significantly prolonged, which provides a safer and more reliable candidate for developing new anti-tumor drugs.
CPC Classifications
C07D 243/14
C07D 243/08
A61P 35/00
A61P 35/02
C07B 2200/05
C07B 59/002
Filing Date
2021-10-25
Application No.
18252039
Claims
16